Clinical Trial

A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a multicenter, randomized, single-masked, active-controlled, parallel, Phase III pivotal study in China
Trial Details
NCT Number NCT07136805
Lead Sponsor VivaVision Biotech, Inc
Conditions Non-infectious Anterior Uveitis
Enrollment 152 participants
Start Date 2025-10-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-22